To qualify for Wegovy, youll typically need one of the following: A BMI of 30 or higher (classified as obesity ), or A BMI of 27 or higher with at least one weight-related health condition Weight-related conditions may include: High blood pressure (hypertension) High cholesterol (dyslipidemia) Type 2 diabetes Heart disease Obstructive sleep apnea Polycystic ovary syndrome ( PCOS ) In addition, in March 2024 the FDA expanded Wegovys approval to include reducing the risk of major cardiovascular events like heart attac k, stroke, and cardiovascular death in adults with cardiovascular disease plus overweight or obesity
in Catalase in Bergmeyer Hans UlrichMethods of Enzymatic Analysis
However, more research is needed to understand how durable these changes are without medication
Certain medications may require closer monitoring when taken with semaglutide, especially those that affect blood sugar, digestion, or appetite
I pledge to model professional conduct in all my public communications and actions.
PlexusDx's personalized approach means your treatment plan evolves based on your unique biology, not just standard protocols